What's new at the NMI? What is happening at the NMI and in the research landscape?Find out more about the NMI!
19.2.2021
The antibody test developed in Reutlingen is sensitive and accurate. This is also confirmed by independent experts who reviewed the validation study prior to its publication.
[read more]
16.2.2021
We are pleased to announce the funding of Wellcome Leap under the HOPE program to develop a novel multi-organ chip with partners from academia and industry.
12.2.2021
The NMI has received funding from the German Research Foundation (DFG) to investigate the impact of stress on health.
15.1.2021
Dr.-Ing. René von Metzen, department head at the NMI, was elected spokesperson for the Micro Medical Technologies Expert Group ...
27.11.2020
Since November 2020, the NMI is a partner in the international ZIM network "4D Bioprinting" (FKZ 16KN098801). This network consists of European SMEs and research institutions that are jointly researching innovative bio inks and ...
18.11.2020
Kathrin Stadelmann, scientist of the Biomedical Micro and Nano Engineering group at the NMI, won the second prize at the Young Scientists Lecture.
3.7.2020
A nationwide antibody study by the Helmholtz Centre for Infection Research (HZI) was launched in the district of Reutlingen at the beginning of July with the aim of gaining a better overview of the occurrence of SARS-CoV-2 infections.
25.6.2020
While the Innovation Alliance Baden-Württemberg, in short innBW, can already look back on a long history, the 13 member institutes joined together to form an association on 24 June.
10.6.2020
The NMI is collaborating in an international project consortium named CORESMA in which clinical, epidemiological and immunological data will be collected and triangulated to assist healthcare systems in their effort to make evidence-based decisions regarding the corona Crisis.
13.5.2020
The NMI Reutlingen is currently tackling a major problem associated with antibody tests for the detection of COVID-19: false positive test results.
6.5.2020
NMI supports the University Hospital of Tübingen in clarifying the material question.
25.3.2020
The NMI Natural and Medical Sciences Institute at the University of Tübingen is focusing its research efforts into infections with the novel coronavirus (SARS-CoV-2).
Durch die Nutzung dieser Webseite erklären Sie sich mit der Verwendung von Cookies einverstanden. Detaillierte Informationen über den Einsatz von Cookies auf dieser Webseite erhalten Sie in der Datenschutzerklärung.
Tools, die wesentliche Services und Funktionen ermöglichen, einschließlich Identitätsprüfung, Servicekontinuität und Standortsicherheit. Diese Option kann nicht abgelehnt werden.
Tools, die anonyme Daten über Website-Nutzung und -Funktionalität sammeln. Wir nutzen die Erkenntnisse, um unsere Produkte, Dienstleistungen und das Benutzererlebnis zu verbessern.
Integration von Social Media Plugins.
